Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Moderna, Pfizer Stocks Fall
Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS
Shares of vaccine makers lost ground Thursday, hit by news that President-elect Donald Trump was naming vaccine skeptic and former presidential hopeful Robert F. Kennedy Jr. as his pick to lead the U.
Moderna, Pfizer Stocks Fall After Reports of RFK Jr. Nomination
Shares of vaccine-makers fell after reports that Donald Trump is expected to nominate vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Shares of Moderna (MRNA
With RFK Jr. Set To Join Trump’s Team, Pfizer, Moderna, And Other Vaccine Stocks Slump
President-elect Donald Trump reportedly tapped anti-vaccine activist Robert F Kennedy Jr to lead the Department of Health and Human Services. While Trump is yet to make an official announcement, Pfizer,
1h
Cambridge firefighters respond to hazmat incident at Pfizer laboratory
Several people were evaluated by paramedics at the scene and one firefighter was taken to a local hospital “as a precaution,” ...
2d
Exclusive: Pfizer explores sale of hospital drugs unit, sources say
Pfizer is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist ...
AOL
23h
The Oncology Bet Is Already Paying Off For Pfizer
With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier in ...
3d
Pfizer: The Tide Finally Turning
Pfizer, a multinational pharmaceutical and biotechnology corporation, is now a $159 billion (by market cap) healthcare giant.
STAT
2d
How Pfizer used wearables to tap into the promise of an experimental drug
Pfizer's head of digital devices says the industry is close to a 'revolution' in using measures from wearables in clinical ...
FierceBiotech
2d
Centessa drops phase 2 hemophilia B drug in wake of Pfizer’s Hympavzi approval
Centessa had recently conducted an interim analysis of a phase 2 study of its drug, called SerpinPC, which is designed to ...
7d
3 Reasons Pfizer Looks Like a No-Brainer Buy Right Now
Pfizer has a pill it's developing called danuglipron, which is in early-stage trials but has demonstrated that it's ...
Business Insider
2d
Pfizer said to be exploring sale of hospital drugs unit, Reuters reports
Pfizer
(PFE) is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist investor Starboard Value, looks to divest non-core assets, Reuters’ ...
6d
Pfizer: Discounted For A Reason - But Dividend Story Remains Rich
Analysis of Pfizer's financial performance, acquisitions, and future prospects, highlighting key challenges and opportunities ...
Zacks.com on MSN
1d
Down -11.04% in 4 Weeks, Here's Why You Should You Buy the Dip in Pfizer (PFE)
Pfizer
(PFE) has been on a downward spiral lately with significant selling pressure. After declining 11% over the past four ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Trump
Moderna
United States Department of Health and Human Services
Feedback